Biodesix, Inc. (BDSX) vs Fulgent Genetics, Inc. (FLGT)
Biodesix, Inc. and Fulgent Genetics, Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $593.0M against $310.2M — 1.9× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against 6.83%. Fulgent Genetics, Inc. has the higher net margin (−26.1% vs −27.0%) and the higher return on invested capital (−10.3% vs −49.6%). Across the 18 metrics below, Biodesix, Inc. leads on 9 and Fulgent Genetics, Inc. on 9.
Valuation
Profitability
| Metric | BDSX | FLGT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 82.50% | 35.58% | 50.89% |
| Operating margin | (20.02%) | (37.75%) | (8.57%) |
| Net margin | (26.97%) | (26.05%) | (6.37%) |
| Free cash flow margin | (19.82%) | (32.04%) | 0.00% |
| Return on equity | (540.01%) | (8.01%) | (2.92%) |
| Return on assets | (30.33%) | (7.37%) | (6.71%) |
| Return on invested capital | (49.60%) | (10.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack